Adma Biologics (ADMA) Change in Intangibles (2023 - 2025)
Adma Biologics (ADMA) reported Change in Intangibles of $192000.0 for Q4 2025, up 2842.86% on a YoY basis from $6524.3 in Q4 2024, and up 82.86% quarter-over-quarter from $105000.0 in Q2 2025.
Adma Biologics (ADMA) Change in Intangibles (2023 - 2025) Analysis & Trends
Adma Biologics has reported Change in Intangibles for 3 years, with the latest figure at $192000.0 in Q4 2025.
- For the quarter ending Q4 2025, Change in Intangibles rose 2842.86% year-over-year to $192000.0; the trailing twelve-month figure through Dec 2025 stood at $316000.0 (down 9.46% YoY), and the FY2025 full-year result was $316000.0, down 9.46% from the prior year.
- Change in Intangibles for Q4 2025 stood at $192000.0, up from $105000.0 in the prior quarter.
- The five-year high for Change in Intangibles was $299000.0 in Q2 2024, with the low at -$7000.0 in Q4 2024.
- Historically, Change in Intangibles has averaged $109375.0 across 3 years, with a median of $73500.0 in 2024.
- Annual changes were most pronounced in 2024 — Change in Intangibles plunged 103.33% — and 2025, when it jumped 2842.86%.
- Adma Biologics' Change in Intangibles stood at $210000.0 in 2023, then plunged by 103.33% to -$7000.0 in 2024, then jumped by 2842.86% to $192000.0 in 2025.
- The last three Change in Intangibles figures came in at $192000.0 (Q4 2025), $105000.0 (Q2 2025), and $19000.0 (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.96 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Adma Biologics | 1.98 Bn | 1.89 Bn | 88.82 Mn | 192,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 192,000.00 |
| Dec 31, 2025 | 192,000.00 |
| Jun 30, 2025 | 105,000.00 |
| Jun 30, 2025 | 105,000.00 |
| Mar 31, 2025 | 19,000.00 |
| Mar 31, 2025 | 19,000.00 |
| Dec 31, 2024 | -7,000.00 |
| Dec 31, 2024 | -7,000.00 |
| Sep 30, 2024 | 42,000.00 |
| Sep 30, 2024 | 42,000.00 |
| Jun 30, 2024 | 299,000.00 |
| Jun 30, 2024 | 299,000.00 |
| Mar 31, 2024 | 15,000.00 |
| Mar 31, 2024 | 15,000.00 |
| Dec 31, 2023 | 210,000.00 |
| Dec 31, 2023 | 210,000.00 |